Open access
Sep 2026
Serum Neurofilament Light Chain and GFAP in Amyotrophic Lateral Sclerosis on a Commercial ECLIA Platform
This work assessed whether ECLIA NfL correlates with the ALSFRS‐R decline rate under the sampling conditions of clinical practice, and whether GFAP or S‐100B adds prognostic or disease‐specific information.
N. Streicher
· Muscle and Nerve · 0 citations